Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Hypercalcemia × Cinacalcet × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Parathyroid Neoplasms 2 Hyperparathyroidism, Primary 2 Hyperparathyroidism 2 Neoplasm Metastasis 1 Hyperparathyroidism, Secondary 1 Hypercalcemia 1 Chronic Kidney Disease-Mineral and Bone Disorder 1

Interventions

Denosumab 1 Cinacalcet 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01460030 2017-03-03

An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism

Kyowa Kirin Co., Ltd.

Phase 3 Completed

Hypercalcemia, Parathyroid Neoplasms, Hyperparathyroidism, Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡